a month ago
BLSM
AnalystsMichael SchmitzMichael Schmitz's Stock Forecasts
AnalystsMichael Schmitz
Sectors:
Analyst Ranking
Top 18%
#984 out of 5550 analysts
Average Return
+23.98%
Win Rate
48%13 out of 27
Risk vs Reward
Poor
Good
Michael Schmitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Erasca IncERAS | +456.20% | $2.58 | $14.35 | 2025-11-14 - 2026-10-30 | Strong Buy |
Sunnova Energy International IncNOVA | +340.54% | $11.42 | $50.31 | 2020-01-06 - 2021-01-06 | Strong Buy |
Merus NvMRUS | +87.92% | $50.10 | $94.15 | 2024-10-01 - 2025-09-30 | Strong Buy |
Exelixis IncEXEL | +52.98% | $36.94 | $56.51 | 2025-07-29 - 2026-07-28 | Strong Buy |
Blueprint Medicines CorpBPMC | +33.85% | $96.72 | $129.46 | 2024-08-02 - 2025-07-17 | Strong Buy |
Michael Schmitz Analyst Color
Get additional color on Michael Schmitz's coverage of popular stocks
2 months ago
RVMD
3 months ago
ONC
3 months ago
URGN
Michael Schmitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Blossomhill Therapeutics IncBLSM | 1 | Strong Buy | $40.00 | +190.91% | Maintains | a month ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $275.00 | +43.75% | Maintains | 2 months ago |
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $45.00 | +202.62% | Reiterates | 3 months ago |
Beone Medicines LtdONC | 1 | Strong Buy | $430.00 | +16.11% | Maintains | 3 months ago |
Urogen Pharma LtdURGN | 1 | Strong Buy | $58.00 | +77.26% | Maintains | 3 months ago |
Enliven Therapeutics IncELVN | 1 | Strong Buy | $78.00 | +76.27% | Maintains | 3 months ago |
Erasca IncERAS | 1 | Strong Buy | $5.00 | -65.16% | Maintains | a year ago |
Mersana Therapeutics IncMRSN | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Merus NvMRUS | 3 | Hold | $97.00 | N/A | Downgrades | a year ago |
Genmab AGMAB | 1 | Strong Buy | $43.00 | N/A | Upgrades | a year ago |
Exelixis IncEXEL | 1 | Strong Buy | $45.00 | N/A | Reiterates | a year ago |
Blueprint Medicines CorpBPMC | 8 | Strong Buy | $138.00 | N/A | Maintains | 2 years ago |
Arvinas IncARVN | 1 | Strong Buy | $40.00 | N/A | Upgrades | 3 years ago |
Fate Therapeutics IncFATE | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Imago Biosciences IncIMGO | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 5 years ago |
Sunnova Energy International IncNOVA | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 7 years ago |
Enbridge Energy Management L L CEEQ | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Enbridge Energy Partners LPEEP | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Tc Pipelines LPTCP | 1 | Hold | $61.00 | N/A | Initiates Coverage On | 10 years ago |
Magellan Midstream Partners LPMMP | 3 | Strong Buy | $80.00 | N/A | Initiates Coverage On | 10 years ago |
Anadarko Petroleum CorpAPC1 | 1 | Strong Buy | $85.00 | N/A | Initiates Coverage On | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.